Addiction is a dependence on a substance where the individual who is affected feels defenseless and unable to stop the obsession to use a substance or prevent a particular behavior. Millions of Americans have addictions to drugs, alcohol, nicotine, and even to behaviors such as obsessive gambling. Pharmacotherapy is a treatment process in which a counselor can use a particular drug to counter act an addictive drug or behavior. Not all counselors agree with this type of treatment. However in order to provide a client with an ethical treatment and unbiased opinions they should be made aware of all scientific evidence of different treatment options. “Thus, attention to addiction pharmacotherapy is an ethical mandate no matter what prejudices a counselor may have” (Capuzzi & Stauffer, 2008, p. 196). Some particular pharmacotherapy’s a counselor may use for the treatment of addiction are Bupropion (Wellbutrin, Zyban), Disulfiram (Antabuse), Naltrexone (ReVia, Depade), Methadone (Dolophine), and Buprenorphine (Temgesic, Suboxone).
Bupropion (Wellbutrin, Zyban) is used in the Pharmacotherapy of Nicotine Addiction. Bupropion is an anti-depressant that stimulates a release of a chemical called dopamine in the reward center area of the brain that causes pleasure (Healthwise, 2009). When an individual smokes, dopamine is released. Therefore Bupropion has the same effect but without the nicotine drug. Bupropion removes the craving an individual has for a cigarette. A few common side effects are weight loss, nausea, and headaches. A more sever side effect is suicidal thoughts and seizures (Healthwise, 2009). Bupropion is a good use to help curb the appetite of a smoker. However when used in correlation with nicotine replacement therapy the ph...
... middle of paper ...
...ctive drugs for the pharmacotherapy to treat opioid addiction. However, these drugs are addictive and will take some time for an individual to slowly stop using them and prevent withdrawal symptoms.
References
Arias, M.D., A. J., & Kranzler, M.D, H. R. (n.d). Treatment of co-occurring alcohol and other drug Use disorders. Retrieved from http://pubs.niaaa.nih.gov/publications/arh312/155-167.htm
Capuzzi, D., & Stauffer, M. D. (2008). Foundations of addictions counseling. Boston, M.A: Pearson Education.
Colker, A. C. (2004). Pharmacotherapy treatment of alcoholism and drug addiction: Overview and bibliography. Retrieved from http://www.ncsl.org/default.aspx?tabid=14417
Healthwise. (2009). Bupropion hydrochloride (Zyban) for quitting smoking. Retrieved from WebMD website: http://www.webmd.com/smoking-cessation/bupropion-hydrochloride-zyban-for-quitting-smoking
Fortinash, K. M., & Holoday Worret, P. A. (Eds.). (2012). Substance-related disorders and addictive behaviors. Psychiatric mental health nursing (5th ed., pp. 319-362). St. Louis, MO: Elsevier Mosby.
Smyth, N. (1994). Addictions counseling: a practical guide to counseling people with chemical and other addictions/The addiction process: effective social work approaches/Clinical work with substance-abusing clients (book). Social Work, 39(5), 616.
4. Elsevier Science, Ltd. (1994). Self-Help and Science in the Treatment of Addiction. Journal of Substance Abuse Treatment, Vol. II. Dr. Don Des Jarlais.
The cognitive behavioral models say that incentives make way for the right conditions for the need for drug abuse. Drug use is associated with experiences such as self-exploration, religious insights, altering moods, escaping boredom or despair, enhancing creativity, performance, sensory experience or pleasure, and so on (Capuzzi & Stauffer, 2012). Cognitive behaviorism has brought in appreciated data at the same time refining theories and treatments. This model stands out from other addiction models because it stands out from the expressive, organic or public causes for addiction. Because it focuses on the patient's own beliefs rather than the influence is the primary focus. The mental process of cognition is related to perception, judgment and reasoning. Cognitive behaviorism affects a person mentally as well as their physical reaction to stimuli. Example, if a person is depressed, the depression is mental but when a person cannot get out of bed, doesn’t want to eat or don’t want to partake in other activities that they usually do is the physical. The factor that can cause a person to use are become a victim to substance abuse and began drug addiction by using drugs to get away from or numb themselves from their depression.
Co-occurring disorders is a term that can be very broad and can describe different conditions that happen or occur at the same time. For the purpose of this essay and from the mental health perspective co-occurring disorders refer to someone who has a substance use disorder such as alcohol or drugs, and also has a mental disorder such as depression or any other mental illness. According to a study conducted in 2014 by the Substance Abuse and Mental Health Services Administration (SAMHSA) adults 18 and over who were surveyed reported having a substance use and/or mental illness. “Of these, 7.9 million people had both a mental disorder and substance use disorder” (SAMHSA, 2016). This essay will provide general history information about co-occurring disorders, how the term came about, treatment integration and the quadrants, as well as a personal view on the use of the co-occurring term.
Sacks, S., Chandler, R., & Gonzales, J. (2008). Responding to the challenge of co-occurring disorders: Suggestions for future research. Journal of Substance Abuse Treatment, 34(1), 139-146
There are many options for substance addiction treatment and utilizing medication as a means of eliminating substance use is one that has been called a double edge sword. There are two schools of thought with medically assisted treatment. First, let 's define medication assisted treatment (MAT): “it is the use of pharmacological medications, in combination with counseling and behavioral therapies, to provide a “whole patient” approach to the treatment of substance use disorders. Research indicates that a combination of medication and behavioral therapies can successfully treat substance use disorders, and for some people struggling with addiction, MAT can help sustain recovery” (Watkins, 2016). One side of this treatment option is that it provides that extra little nudge to start recovery with less or more withdrawal symptoms. For example, disulfiram is an alcohol aversion agent, that when taken with alcohol the person becomes very ill (Watkins, 2016). There are also other medications that help with reducing symptoms of withdrawal, such as methadone.
May, G. (1988). Addiction & Grace: Love and Spirituality in the Healing of Addictions. New York, NY: HarperCollins.
MacMaster, S. (2004). Harm reduction: a new perspective on substance abuse services. Social Work, 49(3), 356-63. Retrieved from http://libproxy.library.unt.edu:2055/docview/215270642/fulltext?accountid=7113
Alcohol is the most commonly used addictive substance in the US. One in every 12 adults suffers from alcohol abuse. Alcohol addiction is very common in modern ...
Liehr, P, Marcus, M, Carroll, D, Granmayeh, K L, Cron, S, Pennebaker, J ;( Apr-Jun 2010). Substance Abuse; Vol. 31 (2); 79-85. Doi: 10.1080/08897071003641271
King, J. H., & Anderson, S. M. (2004). Therapeutic implications of pharmacotherapy: Current trends and ethical issues. Journal of Counseling and Development, 82(3), 329–336.
Silverman, K., Roll, J., & Higgins, S. (2008). Introduction to the Special Issue on the Behavior Analysis and Treatment of Drug Addiction. Journal of Applied behavior Analysis, 41(4), 471-480. Retrieved June 12, 2011, from the proquest.com.navigator-ship.passhe.edu database.
To begin with, in order for a facility to be successful in treating people with addictions whether it be alcohol, or drugs the facility must have a treatment plan to use and guide both counselors and the client alike to be successful in the program.
Substance use disorders and mental health disorder can be challenging for human services professionals as well as for the individual; combined these disorders together and treatment can be seemingly insurmountable. The complexity of the disorders separately, as well as together raises the need for treatment that looks at the whole person not just a set of symptoms. The debate between which disorder came first is useless at helping to resolve the problems that are currently occurring with these complex disorders. According to Stevens & Smith (2013), over five million adults have a co-occurring disorder. With such high number it’s no surprise that the amount of money that is spending on co-occurring disorders is staggering and far exceeds that